Este sitio usa cookies, propias y de terceros.
Si se continúa con nosotros entendemos que se acepta el uso de cookies.

Congreso AHA 2012

Tema en 'Docencia y entrenamiento' comenzado por Belladonna, 1 Nov 2012.

Estado del tema:
No está abierto para más respuestas.
  1. Belladonna

    Belladonna Super Moderator Miembro del Equipo

  2. Belladonna

    Belladonna Super Moderator Miembro del Equipo

    Respuesta: Congreso AHA 2012

    Late-Breaking Clinical Trials, AHA 2012
    Resultados de los Late-Breaking Clinical Trials.

    Domingo, 4 noviembre 2012 / Sunday, Nov. 4, 2012

    Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial. Randomized Trial of Bedside Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus Standard of Care in Patients Undergoing Drug Eluting Stent Implantation: The ARCTIC Study.
    First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial - The TRILOGY ACS Platelet Function Sub-study.
    Results of the Trial to Assess Chelation Therapy.
    Main Results of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
    Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography.
    Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery.
    Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT).
    Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial.

    Lunes, 5 noviembre 2012 / Monday, Nov. 5, 2012

    Omega-3 fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a double-blind randomized clinical trial (FORWARD) (NCT00597220). Oil for the Prevention of Post-Operative Atrial Fibrillation - The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial.
    A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II.
    Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE).
    Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Interim Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
    Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study.
    Effects of 12 Weeks of Treatment with RN316 (PF-04950615), a Humanized IgG2Δa Monoclonal Antibody Binding Proprotein Convertase Subtilisin Kexin Type 9, in Hypercholesterolemic Subjects on High and Maximal Dose Statins.
    Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome.

    Martes, 6 noviembre 2012 / Tuesday, Nov. 6, 2012

    Results of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (Swiss Ami) Trial. Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarction: The NHLBI and CCTRN TIME Trial.
    Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy.
    Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial Up to 2 Years After Therapy.
    MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT-RIT).
    Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF Study).
    Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Hospital Cardiac Arrest.
    The RELAXin in Acute Heart Failure (RELAX-AHF-1) Trial.
    Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network.
Estado del tema:
No está abierto para más respuestas.

Comparte esta página